about
Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studiesIncreased cyclin-dependent kinase 6 expression in bladder cancer.The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer.Polymorphism at P21 codon 31 and dinucleotide polymorphism of P73 gene and susceptibility to bladder cancer in individuals from North IndiaUrinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.Increased SPHK1 expression is associated with poor prognosis in bladder cancer.Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai.The determination of serum and urinary endocan concentrations in patients with bladder cancer.CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population.Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis.Green Tobacco Sickness among Brazilian farm workers and genetic polymorphisms.LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer.Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma.Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population.N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.Detection of CYP1A1 and GSTP1 gene polymorphisms in bladder cancer patients in a Turkish population using a polymerase chain reaction-restriction fragment length polymorphism method.
P2860
Q35643802-2A90436F-ABCD-45C3-A494-888EA476EFA2Q36099328-D2ADB461-3695-4576-8B85-D98D24E080CBQ36328938-81EC0DBC-1EC8-42E9-BF4D-7EC6D057A271Q37345380-1A9666CB-DA77-458A-95B3-0538A4DC3136Q38220806-3270B3C0-10B3-49BA-9644-5C27B897A82AQ38394714-23044C6F-FF38-4ADB-ACAF-34DFD25572FCQ39880356-F69D0A7A-69F1-4EB2-8ED7-0890054F5572Q40839414-A0C33DB5-30D3-43CC-B9AE-8FAB8251D6A4Q46438256-592D5C49-7A01-4ADF-9980-3BCCB7D00AF3Q47135882-29565332-40C6-425B-87FF-F62B005D2BEBQ48252122-B91806AA-CF32-42B2-AFC8-5D14161ED813Q48593750-0B4C7986-0148-4501-B210-871BB43BFF99Q53366239-F2545613-E789-46D4-BCCD-022D351D0CDFQ53572837-2F53DB97-3EFB-41BB-A559-ECE1E6F7DD4FQ54185930-1ED02970-1C44-4F84-BC51-6FA1936268EAQ55065018-32B97477-ACC5-477D-847C-44BF0CC7AA8D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene polymorphisms in bladder cancer.
@en
Gene polymorphisms in bladder cancer.
@nl
type
label
Gene polymorphisms in bladder cancer.
@en
Gene polymorphisms in bladder cancer.
@nl
prefLabel
Gene polymorphisms in bladder cancer.
@en
Gene polymorphisms in bladder cancer.
@nl
P2093
P1433
P1476
Gene polymorphisms in bladder cancer.
@en
P2093
Dusan Dobrota
Erika Halasova
Eva Bukovska
Jan Luptak
Maria Franekova
P356
10.1016/J.UROLONC.2006.10.011
P577
2007-10-29T00:00:00Z